Genetics and Phantom Limb Pain
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01517061|
Recruitment Status : Withdrawn
First Posted : January 25, 2012
Last Update Posted : April 3, 2018
- Many people who lose a limb feel pain in the missing limb. This feeling is called phantom limb pain. Researchers do not fully understand what causes this pain. Differences in people's genes may play a role. Comparing the genes of people with and without phantom limb pain may help researchers better understand this feeling, who is likely to develop it, and how to treat it.
- To study whether genetic differences affect phantom limb pain.
- Individuals at least 18 years of age who have lost an arm or leg at least 3 months ago.
- Participants will be screened with a medical history and physical exam.
- Participants will answer questions about how they lost the limb, and whether they feel phantom limb pain. They will also have a test to measure their sensitivity to heat and cold.
- Participants will provide a blood sample for genetic testing.
|Condition or disease|
|Polymorphism-Genetic Amputation Pain|
The proposed clinical trial will investigate the role of the human genome including genetic variations and gene expression profiles on the development of phantom limb pain (PLP).
Patients will be recruited from military personnel with major limb amputations. A total of one thousand subjects with upper or lower extremity amputations of any level will be enrolled in this study.
Eight hundred subjects with chronic PLP (PLP patient) and 200 patients without PLP (non-PLP patient) will assess the severity of their pain symptom. Each participant will undergo a routine blood draw from which DNA and RNA will be harvested.
Using Affymetrix SNP 6.0 technology, which identifies up to 1 million single nucleotide polymorphisms (SNPs) and 1 million copy number variations in the human genome, the differences in genomic variations between the PLP and the non-PLP patients will be analyzed. An extreme subset of PLP patients will be tested for their quantitative sensory function and profiled gene expression and epigenetic pattern with the Affymetrix Human Exon ST 1.0 and Illumina Genome Analyzer IIx. These integrative genomic analyses using genetic variations, gene expression and epigenetic profile could explain why some amputees experience chronic PLP and some do not. By studying these responses in patient samples, we will evaluate the role of genomic factors in PLP. SNP frequencies, gene expression and epigenetic profiles between PLP and non-PLP groups will be analyzed.
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Integrative Genomic Analysis In Phantom Limb Pain|
|Study Start Date :||January 3, 2012|
|Study Completion Date :||July 30, 2014|
- SNP frequency between PLP and non-PLP group
- Gene expression profile between PLP and non-PLP group
- Epigenetic profile between PLP and non-PLP group
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01517061
|Principal Investigator:||Hyungsuk Kim, D.D.S.||National Institute of Nursing Research (NINR)|